EBV-Specific CD8+ T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Hofland, Tom [1 ,2 ]
de Weerdt, Iris [1 ,2 ]
Terpstra, Sanne [1 ,2 ]
Remmerswaal, Ester B. M. [2 ,3 ]
ten Berge, Ineke J. M. [2 ,3 ]
Kater, Arnon P. [1 ,4 ]
Tonino, Sanne H. [1 ,4 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Expt Immunol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Renal Transplant Unit, NL-1105 AZ Amsterdam, Netherlands
[4] LYMMCARE, Lymphoma & Myeloma Ctr Amsterdam, Amsterdam, Netherlands
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EBV-specific CD8+ T-cells are more activated in patients with early multiple sclerosis
    Jilek, S.
    Schluep, M.
    Vingerhoets, F.
    Guignard, L.
    Kleeberg, J.
    Le Goff, G.
    Pantaleo, G.
    Du Pasquier, R. A.
    MULTIPLE SCLEROSIS, 2007, 13 : S144 - S144
  • [2] CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia
    te Raa, G. Doreen
    Pascutti, Maria Fernanda
    Garcia-Vallejo, Juan J.
    Reinen, Emilie
    Remmerswaal, Ester B. M.
    ten Berge, Ineke J. M.
    van Lier, Rene A. W.
    Eldering, Eric
    van Oers, Marinus H. J.
    Tonino, Sanne H.
    Kater, Arnon P.
    BLOOD, 2014, 123 (05) : 717 - 724
  • [3] EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cells
    Popescu, I.
    Macedo, C.
    Abu-Elmagd, K.
    Shapiro, R.
    Hua, Y.
    Thomson, A. W.
    Morelli, A. E.
    Storkus, W. J.
    Metes, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) : 1215 - 1223
  • [4] Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection
    Precopio, ML
    Sullivan, JL
    Willard, C
    Somasundaran, M
    Luzuriaga, K
    JOURNAL OF IMMUNOLOGY, 2003, 170 (05): : 2590 - 2598
  • [5] Characterization of EBV-specific CD8+T cells in Multiple Sclerosis
    Eleonora, Piras
    Giovanna, Borsellino
    Adamo, Diamantini
    Claudio, Gasperini
    Simona, Galgani
    Grazia, Grasso Maria
    Rosella, Mechelli
    Viviana, Annibali
    Francesca, Aloisi
    Giovanni, Ristori
    Marco, Salvetti
    Giorgio, Bernardi
    Diego, Centonze
    Luca, Battistini
    Francesca, Angelini Daniela
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 117 - 118
  • [6] Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient
    Piriou, ERWAN
    van Dort, K
    Weel, JFL
    Bemelman, FJ
    Gamadia, LE
    van Oers, MHJ
    van Baarle, D
    CLINICAL IMMUNOLOGY, 2006, 119 (01) : 16 - 20
  • [7] Phenotypic and functional analysis of EBV-specific memory CD8 T-cells in SLE patients.
    Berner, BR
    Ott, PA
    Lehmann, PV
    Tary-Lehmann, M
    Anthony, DD
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S196 - S196
  • [8] HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis
    Jilek, Samantha
    Schluep, Myriam
    Harari, Alexandre
    Canales, Mathieu
    Lysandropoulos, Andreas
    Zekeridou, Anastasia
    Pantaleo, Giuseppe
    Du Pasquier, Renaud A.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (09): : 4671 - 4680
  • [9] EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia
    Laura Llaó-Cid
    Philipp M. Roessner
    Vicente Chapaprieta
    Selcen Öztürk
    Tobias Roider
    Marie Bordas
    Ana Izcue
    Dolors Colomer
    Sascha Dietrich
    Stephan Stilgenbauer
    Bola Hanna
    José Ignacio Martín-Subero
    Martina Seiffert
    Leukemia, 2021, 35 : 3152 - 3162
  • [10] EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia
    Llao-Cid, Laura
    Roessner, Philipp M.
    Chapaprieta, Vicente
    Oeztuerk, Selcen
    Roider, Tobias
    Bordas, Marie
    Izcue, Ana
    Colomer, Dolors
    Dietrich, Sascha
    Stilgenbauer, Stephan
    Hanna, Bola
    Martin-Subero, Jose Ignacio
    Seiffert, Martina
    LEUKEMIA, 2021, 35 (11) : 3152 - 3162
12345